Oops! Your browser version is not supported by our website.
Please use these following browsers to view this page:
Hovione today announced the signing of a partnership agreement with Ligand to significantly ramp up the production output of Captisol®
Showing promise in Dry Eye Disease associated with Inflamed Meibomian Gland Dysfunction
Hovione commitment to setting SBTs in line with the Paris Agreement
Spray drying has become one of the most successful particle engineering technologies for improving drug bioavailability through the amorphous solid dispersion platform.
This certification is a recognition of Hovione´s resolve to put people first, and a validation that the investment in HR excellence is delivering.
Hovione is Growing
Google Chrome
Safari
Firefox
Edge